CS logo
small CS logo
Klinik Kesihatan Seremban 2

Seremban, Malaysia

About Klinik Kesihatan Seremban 2


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Livzon Pharmaceutical Group Inc.
1
Seqirus
1
Total Rows: 2

Clinical Trials at Klinik Kesihatan Seremban 2


During the past decade, Klinik Kesihatan Seremban 2 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110000000011000000001100Started TrialsCompleted Trails20162017201820192020202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
2016-09-30
2018-07-23
Completed
6,790
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
2021-11-03
2023-03-14
Active, not recruiting
10,722

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsLivzon PharmaceuticalGroup Inc.: 1Livzon PharmaceuticalGroup Inc.: 1Seqirus: 1Seqirus: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinik Kesihatan Seremban 2


According to Clinical.Site data, the most researched conditions in "Klinik Kesihatan Seremban 2" are "COVID-19 Pandemic" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Klinik Kesihatan Seremban 2" in a lesser frequency.

Clinical Trials Intervention Types at Klinik Kesihatan Seremban 2


Most popular intervention types in "Klinik Kesihatan Seremban 2" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials), "MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)" (1 trials), "Non-Influenza Comparator (Boostrix)" (1 trials) and "Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinik Kesihatan Seremban 2


The vast majority of trials in "Klinik Kesihatan Seremban 2" are 2 trials for "All" genders.

Clinical Trials Status at Klinik Kesihatan Seremban 2


Currently, there are NaN active trials in "Klinik Kesihatan Seremban 2". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinik Kesihatan Seremban 2, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinik Kesihatan Seremban 2, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1